Literature DB >> 23996067

Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.

Christine Schröder1, Karin Milde-Langosch, Florian Gebauer, Katharina Schmid, Volkmar Mueller, Ralph M Wirtz, Catherine Meyer-Schwesinger, Hartmut Schlüter, Guido Sauter, Udo Schumacher.   

Abstract

PURPOSE: The ubiquitin C-terminal hydrolase L1 (UCH-L1) belongs to the family of deubiquitinating enzymes. It is overexpressed in various tumour entities and associated with metastases formation in some solid tumours. However, only limited information about its role in breast cancer is available. The aim of this study was to examine the UCH-L1 expression in primary breast cancer and to determine its relevance as a potential prognostic marker.
METHODS: We investigated both UCH-L1 mRNA expression in microarray data from 182 primary mammary carcinomas and UCH-L1 protein expression using a tissue microarray containing samples from 1,622 breast cancer patients.
RESULTS: With both methods, high UCH-L1 expression correlated significantly with negative oestrogen receptor and progesterone receptor status and advanced tumour stage. Moreover by Kaplan-Meier analysis, high UCH-L1 mRNA and protein expression correlated with a significantly shorter overall survival.
CONCLUSION: The data of our study suggest that high levels of UCH-L1 expression indicate a more aggressive tumour behaviour and might represent a potential target in breast cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996067     DOI: 10.1007/s00432-013-1496-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  35 in total

1.  Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases.

Authors:  K D Wilkinson; S Deshpande; C N Larsen
Journal:  Biochem Soc Trans       Date:  1992-08       Impact factor: 5.407

2.  New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK.

Authors:  Daniel F Hayes; Stephen Ethier; Marc E Lippman
Journal:  Breast Cancer Res Treat       Date:  2006-06-14       Impact factor: 4.872

Review 3.  Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers.

Authors:  D F Hayes; R C Bast; C E Desch; H Fritsche; N E Kemeny; J M Jessup; G Y Locker; J S Macdonald; R G Mennel; L Norton; P Ravdin; S Taube; R J Winn
Journal:  J Natl Cancer Inst       Date:  1996-10-16       Impact factor: 13.506

4.  Silencing of the UCHL1 gene in human colorectal and ovarian cancers.

Authors:  Eriko Okochi-Takada; Kazuyuki Nakazawa; Mika Wakabayashi; Akiko Mori; Shizue Ichimura; Toshiharu Yasugi; Toshikazu Ushijima
Journal:  Int J Cancer       Date:  2006-09-15       Impact factor: 7.396

5.  Tissue microarrays for comparing molecular features with proliferation activity in breast cancer.

Authors:  Christian Ruiz; Silvia Seibt; Khawla Al Kuraya; Abdul K Siraj; Martina Mirlacher; Peter Schraml; Robert Maurer; Hanspeter Spichtin; Joachim Torhorst; Savelina Popovska; Ronald Simon; Guido Sauter
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

6.  Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.

Authors:  S L Rosas; W Koch; M G da Costa Carvalho; L Wu; J Califano; W Westra; J Jen; D Sidransky
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

7.  Significance of PGP9.5 expression in cancer-associated fibroblasts for prognosis of colorectal carcinoma.

Authors:  Yuri Akishima-Fukasawa; Yoshinori Ino; Yukihiro Nakanishi; Ayaka Miura; Yoshihiro Moriya; Tadashi Kondo; Yae Kanai; Setsuo Hirohashi
Journal:  Am J Clin Pathol       Date:  2010-07       Impact factor: 2.493

8.  Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A.

Authors:  Aaron Leiblich; Simon S Cross; James W F Catto; Giancarlo Pesce; Freddie C Hamdy; Ishtiaq Rehman
Journal:  Prostate       Date:  2007-12-01       Impact factor: 4.104

9.  CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma.

Authors:  Ichiro Kagara; Hideki Enokida; Kazumori Kawakami; Ryouichirou Matsuda; Kazuki Toki; Hiroaki Nishimura; Takeshi Chiyomaru; Shuichi Tatarano; Toshihiko Itesako; Ken Kawamoto; Kenryu Nishiyama; Naohiko Seki; Masayuki Nakagawa
Journal:  J Urol       Date:  2008-05-21       Impact factor: 7.450

10.  Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis.

Authors:  J F Doran; P Jackson; P A Kynoch; R J Thompson
Journal:  J Neurochem       Date:  1983-06       Impact factor: 5.372

View more
  9 in total

1.  UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.

Authors:  Yanhong Luo; Jianfeng He; Chunlin Yang; Matthew Orange; Xingcong Ren; Nick Blair; Tao Tan; Jin-Ming Yang; Hua Zhu
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

2.  UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.

Authors:  Honghong Yang; Chunhong Zhang; Shan Fang; Rongying Ou; Wenfeng Li; Yunsheng Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 3.  Deubiquitinases in cancer.

Authors:  Rongbin Wei; Xiaodong Liu; Weixin Yu; Tianshu Yang; Wenping Cai; Junjun Liu; Xiao Huang; Guo-tong Xu; Shouliang Zhao; Jianhua Yang; Shangfeng Liu
Journal:  Oncotarget       Date:  2015-05-30

4.  UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α.

Authors:  Yoko Goto; Lihua Zeng; Chan Joo Yeom; Yuxi Zhu; Akiyo Morinibu; Kazumi Shinomiya; Minoru Kobayashi; Kiichi Hirota; Satoshi Itasaka; Michio Yoshimura; Keiji Tanimoto; Masae Torii; Terumasa Sowa; Toshi Menju; Makoto Sonobe; Hideaki Kakeya; Masakazu Toi; Hiroshi Date; Ester M Hammond; Masahiro Hiraoka; Hiroshi Harada
Journal:  Nat Commun       Date:  2015-01-23       Impact factor: 14.919

5.  Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.

Authors:  Akhileshwar Namani; Md Matiur Rahaman; Ming Chen; Xiuwen Tang
Journal:  BMC Cancer       Date:  2018-01-06       Impact factor: 4.430

6.  Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.

Authors:  Yoshihisa Shimada; Yujin Kudo; Sachio Maehara; Jun Matsubayashi; Yoichi Otaki; Naohiro Kajiwara; Tatsuo Ohira; John D Minna; Norihiko Ikeda
Journal:  Cancer Sci       Date:  2020-01-19       Impact factor: 6.716

Review 7.  UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.

Authors:  Milon Mondal; Daniel Conole; Jaya Nautiyal; Edward W Tate
Journal:  Br J Cancer       Date:  2021-09-08       Impact factor: 7.640

8.  The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.

Authors:  Xinyuan Ding; Yuting Gu; Min Jin; Xin Guo; Sudong Xue; Caihong Tan; Jiefang Huang; Wanlin Yang; Mingxing Xue; Qianjun Zhou; Wenjuan Wang; Yanyun Zhang
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

9.  UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer.

Authors:  Xi-Sha Chen; Kuan-Song Wang; Wei Guo; Lan-Ya Li; Pian Yu; Xin-Yuan Sun; Hai-Yan Wang; Yi-Di Guan; Yong-Guang Tao; Bo-Ni Ding; Ming-Zhu Yin; Xing-Cong Ren; Yi Zhang; Ce-Shi Chen; Yuan-Chao Ye; Jin-Ming Yang; Yan Cheng
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.